NIH Opportunities
HEAL Pain Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) – Notice of Intent to Publish
The planned request for applications (RFA) will support effectiveness clinical trials that propose clinical trials to test the comparative effectiveness of existing therapies or effectiveness of existing or novel approaches for prevention and management of pain while reducing risk of addiction. The overall goal is to inform clinicians about the effectiveness of interventions or management strategies that reduce opioid use that will improve functional outcomes and reduce pain across the continuum of acute to chronic pain associated with many types of diseases or conditions, or pain presenting as a disease itself.
First Due Date: February 1, 2019
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
PAR-19-079, R21 Exploratory/Developmental Grant
PAR-18-712, R01 Research Project Grant
PAR-17-333, R21 Exploratory/Developmental Research Grant
PAR-17-332, R03 Small Grant Program
The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics.
Standard due dates apply.
Federal Non-NIH
Therapeutic Development Award
Pre-Application: March 22, 2019 (Required. Full application submission is by invitation only.)
Application: July 25, 2019
Therapeutic Idea Award
Pre-Application: March 22, 2019 (Required. Full application submission is by invitation only.)
Application: July 25, 2019
Private Funding Opportunities
The Organization for Autism Research is seeking pre-proposals for its 2019 Applied Research Competition. The program aims to promote innovative research that directly supports the autism community by expanding the body of knowledge related to autism intervention and treatment, producing practical and objective results, and providing outcomes that enhance the quality of life for persons with autism and their families.
Preference will be given to the analysis, evaluation, or comparison of current models of assessment, intervention, or systems of service delivery, including policy analysis; applied aspects of educational, behavioral, or social/communicative intervention; effective intervention across the lifespan for individuals considered to be severely impacted by autism; adult issues such as continuing education, employment, residential supports, sexuality instruction, quality-of-life determinants, and "later intervention"; and issues related to family support, social and community integration, assessment and intervention with challenging behavior, and the use of technology in support of learners with ASD.
In 2019, OAR will award grants of up to $40,000. Studies can range from one to two years.
OAR will begin accepting pre-proposals on December 6. Pre-proposals must be received no later than March 25, 2019. Upon review, selected applicants will be invited to submit a full proposal by August 5, 2019.
The LEO Foundation is one of Denmark’s largest commercial foundations. Established in 1984, their main objective is to ensure the long-term independence and success of the global, research-based pharmaceutical company LEO Pharma. LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide. Research project applicants that are within the following criteria are welcome to apply:
- Improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms
- Address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved.
Deadlines: January 3 and March 4, 2019
American Heart Association Artificial Intelligence and Machine Learning Grants are designed at three levels for full investigators, student researchers and clinical student researchers. Grants should describe how to build, test and refine artificial intelligence and machine learning algorithms using varying data sources, which may include, images, electronic health records, wearable devices, smart phones and other sensor-related technology, genetics, biology, and community engagement metrics.
Applications due: January 29, 2019
Cures Within Reach CureAccelerator Live!
For Rare Diseases: Focusing on repurposed treatments impacting patients with any rare disease. Eligible submissions can come from North America and Europe. The event will be held in Spring/Summer 2019 in a US city. Click here to view the full RFP.
For the Developing World: Focusing on repurposed treatments for a disease that primarily impacts patients in low and lower-middle income countries. Eligible submissions can come from anywhere in the world. The event will be held in the Boston area in Spring 2019. Click here to view the full RFP.
CureAccelerator Live! is a philanthropic pitch event from Cures Within Reach where up to 5 PIs are the finalists presenting their clinical repurposing trials and attendees select the winning project and up to $50,000 in funding.
Submissions for both RFPs are due by January 31, 2019.
See additional submission instructions for CureAccelerator Live! PIs here.
The Welch Foundation Research Grant Program supports fundamental chemical research at educational institutions within the state of Texas. A research grant provides a minimum of $65,000 per year in funding to support research in chemistry by a full-time regular faculty member with tenure or on tenure-track who serves as principal investigator. Applications are restricted to universities, colleges, or other educational institutions located within the state of Texas and also listed as an educational institution by the Texas Higher Education Coordinating Board.
Deadline: January 31, 2019 by 1:00 PM EST
The Lupus Research Alliance seeks to fund biomedical research that will discover better diagnostics, improve medical treatments and advance translational and clinical research that will ultimately lead to a cure for lupus. The three grant mechanisms of the organization, Distinguished Innovator Award, Target Identification in Lupus and Novel Research Grant, provide distinct opportunities for researchers to test their most innovative hypothesis by applying cutting edge methodologies to further investigation in the lupus and autoimmune space.
Distinguished Innovator Award deadline: March 15, 2019 at 11:59 pm ET
Target Identification in Lupus & Novel Research Grants deadline: February 1, 2019 at 5:00 pm ET
The Spencer Foundation is intended to investigate ways in which education, broadly conceived, can be improved around the world. The Small Research Grants program is intended to support education research projects with budgets of $50,000 or less. In keeping with the Spencer Foundation’s mission, this program aims to fund academic work that will contribute to the improvement of education, broadly conceived.
Deadline: February 1, 2019, 4:00pm CST